246 related articles for article (PubMed ID: 25435485)
1. p38 Mitogen-activated protein kinase and c-Jun NH2-terminal protein kinase regulate the accumulation of a tight junction protein, ZO-1, in cell-cell contacts in HaCaT cells.
Minakami M; Kitagawa N; Iida H; Anan H; Inai T
Tissue Cell; 2015 Feb; 47(1):1-9. PubMed ID: 25435485
[TBL] [Abstract][Full Text] [Related]
2. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
J Pharmacol Exp Ther; 2009 Jun; 329(3):856-64. PubMed ID: 19286921
[TBL] [Abstract][Full Text] [Related]
3. Anisomycin, a JNK and p38 activator, suppresses cell-cell junction formation in 2D cultures of K38 mouse keratinocyte cells and reduces claudin-7 expression, with an increase of paracellular permeability in 3D cultures.
Nikaido M; Otani T; Kitagawa N; Ogata K; Iida H; Anan H; Inai T
Histochem Cell Biol; 2019 May; 151(5):369-384. PubMed ID: 30284609
[TBL] [Abstract][Full Text] [Related]
4. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
6. The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell.
Chen X; Chen Y; Lin X; Su S; Hou X; Zhang Q; Tian Y
Curr Pharm Biotechnol; 2018; 19(6):506-513. PubMed ID: 30003858
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
Tai TY; Warner LN; Jones TD; Jung S; Concepcion FA; Skyrud DW; Fender J; Liu Y; Williams AD; Neumaier JF; D'Ambrosio R; Poolos NP
Neuroscience; 2017 May; 349():35-47. PubMed ID: 28237815
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
Cho JE; Park S; Cho SN; Lee H; Kim YS
BMB Rep; 2012 Oct; 45(10):583-8. PubMed ID: 23101513
[TBL] [Abstract][Full Text] [Related]
9. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
10. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of c-Jun N-terminal kinase prevents blood-brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage.
Chen D; Wei XT; Guan JH; Yuan JW; Peng YT; Song L; Liu YH
Acta Neurochir (Wien); 2012 Aug; 154(8):1469-76; discussion 1476. PubMed ID: 22661329
[TBL] [Abstract][Full Text] [Related]
12. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
13. Involvement of mitogen-activated protein kinases and protein kinase C in regulation of antioxidant response element activity in human keratinocytes.
Zhu M; Zhang Y; Bowden GT
Cancer Lett; 2006 Dec; 244(2):220-8. PubMed ID: 16455194
[TBL] [Abstract][Full Text] [Related]
14. Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation.
Wu HL; Gao X; Jiang ZD; Duan ZT; Wang SK; He BS; Zhang ZY; Xie HG
Toxicology; 2013 Feb; 304():41-8. PubMed ID: 23220562
[TBL] [Abstract][Full Text] [Related]
15. Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells.
Zhao WX; Tang SS; Jin X; Zhang CM; Zhang T; Wang CC; Sun Y; Xiao XL
Cell Biol Toxicol; 2013 Aug; 29(4):229-38. PubMed ID: 23812630
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice.
Wu D; Cederbaum A
Hepatology; 2008 Mar; 47(3):1005-17. PubMed ID: 18095305
[TBL] [Abstract][Full Text] [Related]
17. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
18. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
[TBL] [Abstract][Full Text] [Related]
19. p38δ mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes.
Siljamäki E; Raiko L; Toriseva M; Nissinen L; Näreoja T; Peltonen J; Kähäri VM; Peltonen S
Arch Dermatol Res; 2014 Mar; 306(2):131-41. PubMed ID: 23856837
[TBL] [Abstract][Full Text] [Related]
20. The role of p38 MAP kinase and c-Jun N-terminal protein kinase signaling in the differentiation and apoptosis of immortalized neural stem cells.
Yang SR; Cho SD; Ahn NS; Jung JW; Park JS; Jo EH; Hwang JW; Kim SH; Lee BH; Kang KS; Lee YS
Mutat Res; 2005 Nov; 579(1-2):47-57. PubMed ID: 16046226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
